cover image - Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases - Elsevier eBook on VitalSource, 10th Edition
ISBN: 9780323935890
Copyright: 2026
Page Count: 4176
Imprint: Elsevier
List Price: $401.99

Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases - Elsevier eBook on VitalSource, 10th Edition

by Martin J. Blaser, MD, Jeffrey I. Cohen, MD and Steven M. Holland, MD

Elsevier eBook on VitalSource

cover image - Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases - Elsevier eBook on VitalSource, 10th Edition
ISBN: 9780323935890
Copyright: 2026
Page Count: 4176
Imprint: Elsevier
List Price: $401.99
Not Yet Available
Most review copies are eBooks – how fast!
A review copy request is most likely to be fulfilled as an eBook on VitalSource rather than a print product, unless no eBook is available. eBooks become available in as little as a few hours. Print products will take between 7 and 10 days to arrive. To request a print copy, please contact us through the Evolve Support Center for further assistance or contact your Education Solutions Consultant.
Coming Soon!
Expected availability date: 06-27-2025
Important note
This is a Faculty Product!
Any student who attempts to request a review copy will be reported to the school's faculty and administration.
    • Organizes content both by individual pathogens and by important clinical syndromes, broadening the context to clearly present relevant, complex clinical information.
    • Contains multiple new chapters on both SARS-CoV-2 and anti-fungal therapy, as well as new chapters on bacteriophages and related agents, infections following traumatic injuries, communication to the public about infectious diseases, and the effects of climate change on infectious diseases.
    • Provides up-to-date coverage of recent advances in the field: an increasing understanding of the agents, immune responses, and the growing armamentarium of diagnostics (such as nucleic acid amplification and next-generation sequencing); new treatments (such as monoclonal antibodies, new antifungals, antivirals, and phage therapy); and emerging preventive measures (such as new vaccines being developed for RSV), and our relationship with the human microbiome.
    • Features more than 1,500 high-quality, full-color photographs―with many new to this edition.
    • Shares the extensive experience of new editors Drs. Jeffrey I. Cohen and Steven M. Holland, both from Bethesda, MD, as well as a new team of expert associate editors Drs. Yohei Doi, Wendy S. Garrett, Ann R. Falsey, Eleanor Wilson, Kieren Marr, and Edward Mitre—each a leading authority in their field.
    • Includes perspectives from hundreds of leading experts from a truly global community, including authors from Australia, Canada, and countries in Europe, Asia, and South America.
    • Includes regular updates online for the life of the edition.
  • PART I: BASIC PRINCIPLES IN THE DIAGNOSIS AND MANAGEMENT OF INFECTIOUS DISEASES
    Section A: Microbial Pathogens
    1. A Molecular Perspective of Microbial Pathogenicity
    2. The Human Microbiome
    3. Prebiotics, Probiotics, and Synbiotics

    Section B: Host Defense Mechanisms
    4. Innate (General or Nonspecific) Host Defense Mechanisms
    5. Adaptive Immunity: Antibodies and Immunodefiencies
    6. Cell-Mediated Defense Against Infection
    7. Mucosal Immunity
    8. Granulocytic Phagocytes
    9. Complement and Deficiencies
    10. Human Genetics and Infection
    11. Nutrition, Immunity, and Infection
    12. Evaluation of the Patient with Suspected Immunodeficiency

    Section C: Epidemiology of Infectious Disease
    13. Principles of Applied Epidemiology for the Practice of Infectious Diseases
    14. Emerging and Reemerging Infectious Disease Threats
    15. Bioterrorism: An Overview

    Section D: Clinical Microbiology
    16. The Clinician and the Microbiology Laboratory: Test Ordering, Specimen Collection, and Result Interpretation

    Section E: Antiinfective Therapy
    17. Principles of Anti-Infective Therapy
    18. Molecular Mechanisms of Antibiotic Resistance in Bacteria
    19. Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents
    20. Penicillins and β-Lactamase Inhibitors
    21. Cephalosporins and Cephalosporin/β-Lactamase Inhibitor Combinations
    22. Carbapenems, Carbapenem/β-Lactamase Inhibitor Combinations, and Aztreonam
    23. Antibiotic Allergy
    24. Aminoglycosides
    25. Tetracyclines, Tetracycline Derivatives, and Chloramphenicol
    26. Rifamycins
    27. Metronidazole
    28. Macrolides and Clindamycin
    29. Glycopeptides (Vancomycin and Teicoplanin) and Lipoglycopeptides (Telavancin, Oritavancin, and Dalbavancin)
    30. Streptogramins (Quinupristin-Dalfopristin) and Lipopeptides (Daptomycin)
    31. Polymyxins (Polymyxin B and Colistin)
    32. Linezolid,Tedizolid, and Other Oxazolidinones
    33. Sulfonamides and Trimethoprim; Trimethoprim-Sulfamethoxazole
    34. Quinolones
    35. Antibiotics in Advanced Development and Other Agents
    36. Urinary Tract Agents: Nitrofurantoin, Fosfomycin and Methenamine
    37. Topical Antibacterials
    38. Antimycobacterial Agents
    39. Bacteriophage Therapy, Endolysin Therapy and Antimicrobial Peptide Therapy
    40. Antifungal Agents: Polyene Antifungals
    41. Antifungal Drugs: Azole
    42. Antifungal Drugs: Echinocandins and Other Beta-D-glucan Inhibitors
    43. Antifungal Drugs: Flucytosine
    44. Antimalarial Drugs
    45. Drugs for Protozoal Infections Other Than Malaria
    46. Drugs for Helminths
    47. Antiviral Agents: General Principles
    48. Antiviral Drugs for Influenza and Other Respiratory Virus Infections Except for SARS-CoV-2
    49. Antivirals Against Herpesviruses
    50. Antiviral Drugs Against Hepatitis Viruses
    51. Miscellaneous Antivirals Agents (Interferons, Tecovirimat, Imiquimod, Pocapavir)
    52. Immunomodulators
    53. Hyperbaric Oxygen
    54. Antimicrobial Stewardship
    55. Designing and Interpreting Clinical Studies in Infectious Diseases
    56. Outpatient Parenteral Antimicrobial Therapy

    PART II: MAJOR CLINICAL SYNDROMES
    Section A: Fever
    57. Temperature Regulation and the Pathogenesis of Fever
    58. Fever of Unknown Origin
    59. The Acutely Ill Patient with Fever and Rash

    Section B: Upper Respiratory Tract Infections
    60. The Common Cold
    61. Pharyngitis
    62. Acute Laryngitis
    63. Otitis Externa, Otitis Media, and Mastoiditis
    64. Sinusitis
    65. Epiglottitis
    66. Infections of the Oral Cavity, Neck, and Head

    Section C: Pleuropulmonary and Bronchial Infections
    67. Acute Bronchitis
    68. Acute Exacerbations of Chronic Obstructive Pulmonary Disease
    69. Acute Pneumonia
    70. Pleural Effusion and Empyema
    71. Bacterial Lung Abscess
    72. Chronic Pneumonia
    73. Cystic Fibrosis

    Section D: Urinary Tract Infections
    74. Urinary Tract Infections

    Section E: Sepsis
    75. Sepsis and Septic Shock

    Section F: Intraabdominal Infections
    76. Peritonitis and Intraperitoneal Abscesses
    77. Infections of the Liver and Biliary System (Liver Abscess, Cholangitis, Cholecystitis)
    78. Pancreatic Infection
    79. Splenic Abscess
    80. Appendicitis
    81. Diverticulitis and Neutropenic Enterocolitis

    Section G: Cardiovascular Infections
    82. Endocarditis and Intravascular Infections
    83. Prosthetic Valve Endocarditis
    84. Infections of Nonvalvular Cardiovascular Devices
    85. Prophylaxis of Infective Endocarditis
    86. Myocarditis and Pericarditis
    87. Mediastinitis

    Section H: Central Nervous System Infections
    88. Approach to the Patient with Central Nervous System Infection
    89. Acute Meningitis
    90. Chronic Meningitis
    91. Encephalitis
    92. Brain Abscess
    93. Subdural Empyema, Epidural Abscess, and Suppurative Intracranial Thrombophlebitis
    94. Cerebrospinal Fluid Shunt and Drain Infections

    Section I: Skin and Soft Tissue Infections
    95. Cellulitis, Necrotizing Fasciitis, and Subcutaneous Tissue Infections
    96. Myositis and Myonecrosis
    97. Lymphadenitis and Lymphangitis

    Section J: Gastrointestinal Infections and Food Poisoning
    98. Syndromes of Enteric Infection
    99. Esophagitis
    100. Diarrhea with Little or No Fever
    101. Acute Dysentery Syndromes (Diarrhea with Fever)
    102. Typhoid Fever, Paratyphoid Fever, and Typhoidal Fevers
    103. Foodborne Disease (Food Poisoning)
    104. Tropical Sprue and Environmental Enteric Dysfunction

    Section K: Bone and Joint Infections
    105. Infectious Arthritis of Native Joints
    106. Osteomyelitis
    107. Orthopaedic Implant-Associated Infections

    Section L: Diseases of The Reproductive Organs and Sexually Transmitted Diseases
    108. Anogenital Skin and Mucous Membrane Lesions
    109. Urethritis
    110. Vulvovaginitis and Cervicitis
    111. Infections of the Female Pelvis
    112. Prostatitis, Epididymitis, and orchitis

    Section M: Eye Infections
    113. Introduction to Eye Infections
    114. Microbial Conjunctivitis
    115. Microbial Keratitis
    116. Endophthalmitis
    117. Infectious Causes of Uveitis
  • Martin J. Blaser, MD, Henry Rutgers Chair of the Human Microbiome, Professor of Medicine and Pathology & Laboratory Medicine - RWJMS; Director, Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, New Jersey, USA, Jeffrey I. Cohen, MD, Bethesda, MD and Steven M. Holland, MD, Bethesda, MD
Not Yet Available
Most review copies are eBooks – how fast!
A review copy request is most likely to be fulfilled as an eBook on VitalSource rather than a print product, unless no eBook is available. eBooks become available in as little as a few hours. Print products will take between 7 and 10 days to arrive. To request a print copy, please contact us through the Evolve Support Center for further assistance or contact your Education Solutions Consultant.
Coming Soon!
Expected availability date: 06-27-2025
Important note
This is a Faculty Product!
Any student who attempts to request a review copy will be reported to the school's faculty and administration.